Login or sign up
For business

Cellsight technologies inc.

4.2· 11 reviews
Average ratingGreat
4.2/ 5

Based on 11 reviews

545%
427%
327%
20%
10%
Ask AI

Ask AI about Cellsight technologies inc.

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Sean Delapp
Reviews 1

Cellsight technologies inc. is a company that provides outstanding services. I had a great experience working with them. Their team is highly professional and knowledgeable. The quality of their work is excellent. I highly recommend Cellsight technologies inc. for all your tech needs.

Anthony Crisci
Reviews 1

I recently had the opportunity to work with a tech company, and they did an outstanding job. The team at Cellsight technologies inc. is highly professional and skilled. The quality of their work is excellent. I would highly recommend them for all your tech needs.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Cellsight technologies inc.

CellSight is developing a suite of PET tracers targeted at visualizing immune response early in a patient's immunotherapy regimen.

Their lead PET imaging tracer targeted at imaging activated T cells is a Fluorine 18 labeled analog of an FDA approved drug ArabinoFuranosylGuanine [18F]F-AraG, trade name VisAcT. VisAcT does not care about the type of immunotherapy regimen being administered – adoptive cell therapy, checkpoint inhibitors, cancer vaccines or a combination of immunotherapy and conventional medicines. VisAcT hones in on and images activated T cells that are critical to any immune modulated therapy.

CellSight's VisAcT PET tracer is currently undergoing clinical trials at University of California San Francisco and will be used to image cancer patients undergoing immunotherapy.

Address
185 berry street
Categories
Biotechnology